These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator. Murakami M; Murakami E; Takekoshi N; Tsuchiya M; Kin T Jpn Heart J; 1972 Mar; 13(2):128-35. PubMed ID: 4537344 [No Abstract] [Full Text] [Related]
23. Hemodynamic effects of an isoquinoline derivative in the treatment of hemorrhagic shock. Kim SI; Nassos TP; Shoemaker WC J Surg Res; 1971 Aug; 11(8):390-5. PubMed ID: 5568819 [No Abstract] [Full Text] [Related]
24. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Rich S; Martinez J; Lam W; Levy PS; Rosen KM Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224 [No Abstract] [Full Text] [Related]
25. Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilator. Sannerstedt R; Brorson L; Berglund G; Werkö L Acta Med Scand; 1975 May; 197(5):409-14. PubMed ID: 238365 [TBL] [Abstract][Full Text] [Related]
27. Effect of sodium nitroprusside on function in the isolated and intact dog kidney. Bastron RD; Kaloyanides GJ J Pharmacol Exp Ther; 1972 May; 181(2):244-9. PubMed ID: 5030670 [No Abstract] [Full Text] [Related]
28. Discussion on the search for an ideal vasodilator: a hemodynamic perspective. Julius S J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S149-53. PubMed ID: 2442508 [No Abstract] [Full Text] [Related]
29. Pathophysiology of propranolol in hypertension. Frohlich ED South Med J; 1977 Jan; 70(1):95-9. PubMed ID: 14402 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of severe arterial hypertension with a new peripheral vasodilator agent (minoxidil)]. Angelino PF; Lavezzaro G Minerva Cardioangiol; 1979 Jun; 27(6):359-64. PubMed ID: 381979 [No Abstract] [Full Text] [Related]
32. Myocardial depression and peripheral vasodilation caused by the administration of chlordiazepoxide. Hitch DC; Nolan SP Surg Forum; 1969; 20():162-4. PubMed ID: 5383037 [No Abstract] [Full Text] [Related]
33. Cardiovascular effects of various agents on cardiogenic shock. Fukushima K Jpn Circ J; 1974 Jun; 38(6):509-13. PubMed ID: 4279996 [No Abstract] [Full Text] [Related]
34. [Vasodilators in the treatment of arterial hypertension]. Gherasim L; Dorobanţu M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):289-302. PubMed ID: 6150533 [No Abstract] [Full Text] [Related]
35. [Treatment of cardiac insufficiency with vasodilators]. Salazar Dávila E Cardiology; 1980; 66 Suppl 2():146-53. PubMed ID: 7285025 [No Abstract] [Full Text] [Related]
36. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure. Rubin SA; Swan HJ Cardiovasc Clin; 1984; 14(3):19-29. PubMed ID: 6144389 [No Abstract] [Full Text] [Related]
37. Diazoxide--an effective vasodilator in accelerated hypertension. Moser M Am Heart J; 1974 Jun; 87(6):791-5. PubMed ID: 4828816 [No Abstract] [Full Text] [Related]